Call for AbbVie Scandinavia Golden Ticket 2026 in partnership with KI Innovations
KI Innovatiions have partnered with AbbVie, a global biopharmaceutical company, to launch a Scandinavia Golden Ticket designed to accelerate companies developing novel, transformational therapies and innovations for immunology, oncology, neuroscience, eye care, aesthetics, or other specialities including obesity, GI and hepatology.
The call has now closed, and we want to thank everyone who applied. We will announce the winner in April so stay tuned!
